//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
News from Jennifer Doudna's lab at UC Berkeley, Innovative Genomics Institute. Tweets from lab members and not Jennifer Doudna unless signed JD. Tweets represent personal views only. doudnalab.org
Doudna Lab








Loading...
and here: www.biorxiv.org/content/10.6...
New pre-print 📣 “Undruggable” cancer mutations remain very hard to target with current modalities. What if we could instead sense mutant transcripts and convert that recognition into selective cell killing? Check out this work led by postdoc Jingkun Zeng: www.biorxiv.org/content/10.6...
Read more here: www.biorxiv.org/content/10.6...
We present VIPR, a phage-encoded RNA-guided system that recognizes DNA with a noncontiguous code unlike CRISPR. Tiny, programmable, possibly ancestral to CRISPR immunity; VIPR is built around a striking RNA-DNA-DNA triplex.
We programmed CRISPR-Cas12a2 to recognize cancer mutations, especially in TP53, and selectively kill mutant cells through transcript-activated chromatin shredding.
1mo
1mo
1mo
1mo
1mo
We now present our latest work, now out in @nature.com! A creative new CRISPR-based approach can selectively destroy cells carrying undruggable mutations in cancer. Work led by @jingkunzeng.bsky.social In collaboration with Alan Ashworth, Yang Liu and Ryan Jackson. www.nature.com/articles/s41...
A big challenge for CRISPR gene editing 🧬 is altering a high enough proportion of target cells in the body 🧪 So @doudna-lab.bsky.social have developed editors that can amplify themselves by spreading from cell to cell Comment from @gaetanburgio.bsky.social www.newscientist.com/article/2514...
Our lab is proud to present our latest work harnessing Bridge Recombinase for genome-scale editing in diverse bacteria, microbiome editing, and programmable horizontal gene transfer.
In our new work published in @natbiomedeng.nature.com in collaboration with @theottlab.bsky.social and @doudna-lab.bsky.social, we introduce "interfering" guide RNAs (igRNA) for CRISPR-Cas13a that regulate enzyme activity after activation. Congrats to all the authors! www.nature.com/articles/s41...
1d
3mo
1mo
Doudna Lab
Doudna Lab
Doudna Lab
Doudna Lab
Doudna Lab
2mo
Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding - Nature
Nature - Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding
www.nature.com
Doudna Lab
Michael Le Page
www.biorxiv.org
www.biorxiv.org
www.biorxiv.org
The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect
Gene editing that spreads within the body could cure more diseases
www.newscientist.com
Cress Lab
A multiplexed RNA detection method exploits crRNA-dependent variability in Cas13a activity on RNA targets for kinetic barcoding and can be used to distinguish among SARS-CoV-2 variants in clinical sam...
www.nature.com
Programmable kinetic barcoding for multiplexed RNA detection with Cas13a - Nature Biomedical Engineering
Fletcher Lab
Excited to share our discovery of a new programmable RNA-guided DNA-targeting system hiding inside bacteriophages that predates CRISPR. We call it VIPR (Viral Interference Programmable Repeat), and it uses an entirely new logic to find its targets. Thread + link below.
1mo
Bridge recombinase enables versatile rewriting of bacterial genomes https://www.biorxiv.org/content/10.64898/2026.04.29.721476v1
1mo
Kenneth Loi